罕见病重症肌无力治疗破局：全球首款FcRn拮抗剂在中国上市

七印授权

5RMEX6K7J3RMLBJPYGWXGGCQH68QGKXZ3HFEG5M5O3FDDBWS35

2023-09-06 09:46:24

article

253D36E40FA2CECBABA8824699B0A17478AE527FE5767B4B6202EC6D4C8704BA

zh-CN

810C6AC3DBE42EC737C2BFAC2D1B6C124E284D4A

15203703

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

31044547027e4d179c140e4d587a5bdd5df7acdfda6177beffdc3c690d59e200530da840fe8772f5c0b928a0f953fd86b7253e4d563f85ad16e68b7fcdf6eebe1c

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"300000"},"type":"cm"}

yuanben_64f84a70276432.20957441

原本认证

33QB5NTMF4LN601MN2DM25THFKD1U7YPRKHFWJLVEJXXMN7EBC

https://www.yuanben.io/article/58755760-ed52-479e-a1ec-39931eea5114

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}